Blood-to-brain influx transport of nicotine at the rat blood-brain barrier: Involvement of a pyrilamine-sensitive organic cation transport process

Neurochemistry International

Volumn 62, Issue 2, 2013, Pages 173-181

  Tega, Yuma ^a   Akanuma, Shin Ichi ^a   Kubo, Yoshiyuki ^a   Terasaki, Tetsuya ^b   Hosoya, Ken Ichi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Blood brain barrier; Nicotine; Organic cation transporter; Pyrilamine

Indexed keywords

CATION; MEPYRAMINE; NICOTINE;

ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CELL; CELL IMMORTALIZATION; CONTROLLED STUDY; ENDOTHELIUM CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; RAT; TEMPERATURE DEPENDENCE;

ANIMALS; BLOOD-BRAIN BARRIER; CARRIER PROTEINS; CATIONS; CELL LINE; MALE; NICOTINE; PYRILAMINE; RATS; RATS, WISTAR; TRITIUM;

NICOTIANA TABACUM; RATTUS;

EID: 84871951155     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2012.11.014     Document Type: Article

References (52)

1. D.D. Allen, and Q.R. Smith Characterization of the blood-brain barrier choline transporter using the in situ rat brain perfusion technique J. Neurochem. 76 2001 1032 1041
2. P. Andre, M. Debray, J.M. Scherrmann, and S. Cisternino Clonidine transport at the mouse blood-brain barrier by a new H(+) antiporter that interacts with addictive drugs J. Cereb. Blood Flow Metab. 29 2009 1293 1304
3. N.L. Benowitz Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics Annu. Rev. Pharmacol. Toxicol. 49 2009 57 71
4. A.E. Busch, S. Quester, J.C. Ulzheimer, S. Waldegger, V. Gorboulev, P. Arndt, F. Lang, and H. Koepsell Electrogenic properties and substrate specificity of the polyspecific rat cation transporter rOCT1 J. Biol. Chem. 271 1996 32599 32604
5. G. Di Chiara Role of dopamine in the behavioural actions of nicotine related to addiction Eur. J. Pharmacol. 393 2000 295 314
6. A. Fukada, H. Saito, Y. Urakami, M. Okuda, and K. Inui Involvement of specific transport system of renal basolateral membranes in distribution of nicotine in rats Drug Metab. Pharmacokinet. 17 2002 554 560
7. O.A. Ghosheh, L.P. Dwoskin, D.K. Miller, and P.A. Crooks Accumulation of nicotine and its metabolites in rat brain after intermittent or continuous peripheral administration of [2′-(14)C]nicotine Drug Metab. Dispos. 29 2001 645 651
8. D. Grundemann, V. Gorboulev, S. Gambaryan, M. Veyhl, and H. Koepsell Drug excretion mediated by a new prototype of polyspecific transporter Nature 372 1994 549 552
9. D. Grundemann, G. Liebich, N. Kiefer, S. Koster, and E. Schomig Selective substrates for non-neuronal monoamine transporters Mol. Pharmacol. 56 1999 1 10
10. S.K. Guthrie, L. Ni, J.K. Zubieta, C.J. Teter, and E.F. Domino Changes in craving for a cigarette and arterial nicotine plasma concentrations in abstinent smokers Prog. Neuropsychopharmacol. Biol. Psychiatry 28 2004 617 623
11. M. Hammarlund-Udenaes, M. Friden, S. Syvanen, and A. Gupta On the rate and extent of drug delivery to the brain Pharm. Res. 25 2008 1737 1750
12. M. Hiasa, T. Matsumoto, T. Komatsu, and Y. Moriyama Wide variety of locations for rodent MATE1, a transporter protein that mediates the final excretion step for toxic organic cations Am. J. Physiol. Cell Physiol. 291 2006 C678 C686
13. K. Hosoya, A. Yamamoto, S. Akanuma, and M. Tachikawa Lipophilicity and transporter influence on blood-retinal barrier permeability: a comparison with blood-brain barrier permeability Pharm. Res. 27 2010 2715 2724
14. K.I. Hosoya, T. Takashima, K. Tetsuka, T. Nagura, S. Ohtsuki, H. Takanaga, M. Ueda, N. Yanai, M. Obinata, and T. Terasaki mRNA expression and transport characterization of conditionally immortalized rat brain capillary endothelial cell lines; a new in vitro BBB model for drug targeting J. Drug Target. 8 2000 357 370
15. M. Inazu, H. Takeda, K. Maehara, K. Miyashita, A. Tomoda, and T. Matsumiya Functional expression of the organic cation/carnitine transporter 2 in rat astrocytes J. Neurochem. 97 2006 424 434
16. S. Itagaki, V. Ganapathy, H.T. Ho, M. Zhou, E. Babu, and J. Wang Electrophysiological characterization of the polyspecific organic cation transporter plasma membrane monoamine transporter Drug Metab. Dispos. 40 2012 1138 1143
17. A. Kakee, T. Terasaki, and Y. Sugiyama Brain efflux index as a novel method of analyzing efflux transport at the blood-brain barrier J. Pharmacol. Exp. Ther. 277 1996 1550 1559
18. Y.S. Kang, T. Terasaki, T. Ohnishi, and A. Tsuji In vivo and in vitro evidence for a common carrier mediated transport of choline and basic drugs through the blood-brain barrier J. Pharmacobiodyn. 13 1990 353 360
19. Y. Kasai, M. Tachikawa, S. Hirose, S. Akanuma, and K. Hosoya Transport systems of serine at the brain barriers and in brain parenchymal cells J. Neurochem. 118 2011 304 313
20. R. Kekuda, P.D. Prasad, X.A. Wu, H.P. Wang, Y.J. Fei, F.H. Leibach, and V. Ganapathy Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta J. Biol. Chem. 273 1998 15971 15979
21. G.A. Kyerematen, and E.S. Vesell Metabolism of nicotine Drug Metab. Rev. 23 1991 3 41
22. A.I. Leshner, and G.F. Koob Drugs of abuse and the brain Proc. Assoc. Am. Physicians 111 1999 99 108
23. E. Levin, L. Icenogle, and A. Farzad Ketanserin attenuates nicotine-induced working memory improvement in rats Pharmacol. Biochem. Behav. 82 2005 289 292
24. E.D. Levin, S. Slade, C. Wells, M. Pruitt, V. Cousins, M. Cauley, A. Petro, D. Hampton, and J. Rose Histamine H(1) antagonist treatment with pyrilamine reduces nicotine self-administration in rats Eur. J. Pharmacol. 650 2011 256 260
25. H.H. Liou, H.J. Hsu, Y.F. Tsai, C.Y. Shih, Y.C. Chang, and C.J. Lin Interaction between nicotine and MPTP/MPP+ in rat brain endothelial cells Life Sci. 81 2007 664 672
26. P.R. Lockman, G. McAfee, W.J. Geldenhuys, C.J. Van der Schyf, T.J. Abbruscato, and D.D. Allen Brain uptake kinetics of nicotine and cotinine after chronic nicotine exposure J. Pharmacol. Exp. Ther. 314 2005 636 642
27. K.Y. Ohta, K. Inoue, Y. Hayashi, and H. Yuasa Molecular identification and functional characterization of rat multidrug and toxin extrusion type transporter 1 as an organic cation/H+ antiporter in the kidney Drug Metab. Dispos. 34 2006 1868 1874
28. T. Okura, A. Hattori, Y. Takano, T. Sato, M. Hammarlund-Udenaes, T. Terasaki, and Y. Deguchi Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone Drug Metab. Dispos. 36 2008 2005 2013
29. T. Okura, R. Ito, N. Ishiguro, I. Tamai, and Y. Deguchi Blood-brain barrier transport of pramipexole, a dopamine D2 agonist Life Sci. 80 2007 1564 1571
30. T. Okura, S. Kato, Y. Takano, T. Sato, A. Yamashita, R. Morimoto, S. Ohtsuki, T. Terasaki, and Y. Deguchi Functional characterization of rat plasma membrane monoamine transporter in the blood-brain and blood-cerebrospinal fluid barriers J. Pharm. Sci. 100 2011 3924 3938
31. W. Oldendorf, L. Braun, and E. Cornford pH dependence of blood-brain barrier permeability to lactate and nicotine Stroke 10 1979 577 581
32. W.H. Oldendorf Measurement of brain uptake of radiolabeled substances using a tritiated water internal standard Brain Res. 24 1970 372 376
33. W.M. Pardridge The blood-brain barrier: bottleneck in brain drug development NeuroRx 2 2005 3 14
34. A.H. Rezvani, D.P. Caldwell, and E.D. Levin Nicotinic-serotonergic drug interactions and attentional performance in rats Psychopharmacology 179 2005 521 528
35. J.E. Rose, A.G. Mukhin, S.J. Lokitz, T.G. Turkington, J. Herskovic, F.M. Behm, S. Garg, and P.K. Garg Kinetics of brain nicotine accumulation in dependent and nondependent smokers assessed with PET and cigarettes containing 11C-nicotine Proc. Natl. Acad. Sci. USA 107 2010 5190 5195
36. H. Sipos, B. Torocsik, L. Tretter, and V. Adam-Vizi Impaired regulation of pH homeostasis by oxidative stress in rat brain capillary endothelial cells Cell. Mol. Neurobiol. 25 2005 141 151
37. T. Terada, S. Masuda, J.I. Asaka, M. Tsuda, T. Katsura, and K.I. Inui Molecular cloning, functional characterization and tissue distribution of rat H+/organic cation antiporter MATE1 Pharm. Res. 23 2006 1696 1701
38. T. Terasaki, S. Ohtsuki, S. Hori, H. Takanaga, E. Nakashima, and K. Hosoya New approaches to in vitro models of blood-brain barrier drug transport Drug Discov. Today 8 2003 944 954
39. R. Toda, K. Kawazu, M. Oyabu, T. Miyazaki, and Y. Kiuchi Comparison of drug permeabilities across the blood-retinal barrier, blood-aqueous humor barrier, and blood-brain barrier J. Pharm. Sci. 100 2011 3904 3911
40. M. Tsuda, T. Terada, J. Asaka, M. Ueba, T. Katsura, and K. Inui Oppositely directed H+ gradient functions as a driving force of rat H+/organic cation antiporter MATE1 Am. J. Physiol. 292 2007 F593 F598
41. A. Tsuji, T. Terasaki, Y. Takabatake, Y. Tenda, I. Tamai, T. Yamashima, S. Moritani, T. Tsuruo, and J. Yamashita P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells Life Sci. 51 1992 1427 1437
42. Y. Urakami, M. Okuda, S. Masuda, H. Saito, and K.I. Inui Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs J. Pharmacol. Exp. Ther. 287 1998 800 805
43. A.L. VanWert, M.R. Gionfriddo, and D.H. Sweet Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology Biopharm. Drug Dispos. 31 2010 1 71
44. V. Vialou, L. Balasse, J. Callebert, J.M. Launay, B. Giros, and S. Gautron Altered aminergic neurotransmission in the brain of organic cation transporter 3-deficient mice J. Neurochem. 106 2008 1471 1482
45. V. Vialou, L. Balasse, S. Dumas, B. Giros, and S. Gautron Neurochemical characterization of pathways expressing plasma membrane monoamine transporter in the rat brain Neuroscience 144 2007 616 622
46. J.S. Wang, J.S. Markowitz, J.L. Donovan, and C.L. Devane P-glycoprotein does not actively transport nicotine and cotinine Addict. Biol. 10 2005 127 129
47. R. West, and S. Shiffman Effect of oral nicotine dosing forms on cigarette withdrawal symptoms and craving: a systematic review Psychopharmacology 155 2001 115 122
48. X. Wu, R.L. George, W. Huang, H.P. Wang, S.J. Conway, F.H. Leibach, and V. Ganapathy Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta Biochim. Biophys. Acta 1466 2000 315 327
49. X. Wu, W. Huang, P.D. Prasad, P. Seth, D.P. Rajan, F.H. Leibach, J.W. Chen, S.J. Conway, and V. Ganapathy Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter J. Pharmacol. Exp. Ther. 290 1999 1482 1492
50. X. Wu, R. Kekuda, W. Huang, Y.J. Fei, F.H. Leibach, J. Chen, S.J. Conway, and V. Ganapathy Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain J. Biol. Chem. 273 1998 32776 32786
51. M. Yamazaki, H. Fukuoka, O. Nagata, H. Kato, Y. Ito, T. Terasaki, and A. Tsuji Transport mechanism of an H1-antagonist at the blood-brain barrier: transport mechanism of mepyramine using the carotid injection technique Biol. Pharm. Bull. 17 1994 676 679
52. S. Yang, and I. Smetena Evaluation of capillary electrophoresis for the analysis of nicotine and selected minor alkaloids from tobacco Chromatographia 40 1995 375 378